Literature DB >> 26722860

Different aspects of dysexecutive syndrome in patients with moyamoya disease and its clinical subtypes.

Lingling Fang1, Jia Huang2, Qian Zhang1, Raymond C K Chan2, Rong Wang1, Weiqing Wan1.   

Abstract

OBJECTIVE Dysexecutive syndrome is common in patients with moyamoya disease (MMD), a chronic cerebrovascular disease that is characterized by stenosis of the bilateral internal carotid arteries and progressive collateral revascularization, and MMD can be classified as ischemic or hemorrhagic according to the disease presentation and history. In this study, the authors aimed to determine which aspects of executive function are impaired in patients with MMD, in addition to the specific dysexecutive functions present among its clinical subtypes and the mechanisms underlying dysexecutive function in these patients. METHODS The authors administered 5 typical executive function tests (the Stroop test, the Hayling Sentence Completion Test [HSCT], the verbal fluency [VF] test, the N-back test, and the Sustained Attention to Response Task [SART]) to 49 patients with MMD and 47 IQ-, age-, education-, and social status-matched healthy controls. The dysexecutive questionnaire (DEX) was also used to assess participants' subjective feelings about their executive function. A total of 39 of the patients were evaluated by CT perfusion (CTP) before the assessments were performed, and the correlations among the performances of the patients on the above tests with the parameters of cerebral blood volume, cerebral blood flow (CBF), mean transit time (MTT), and time-to-peak (TTP) in the frontal lobes of these patients were also analyzed. RESULTS Many aspects of executive function in the patients with MMD were significantly poorer than those in the healthy controls, and the patients performed particularly poorer on the VF test, HSCT, N-back test, and SART. The patients with hemorrhagic MMD exhibited worse executive inhibition, executive processing, and semantic inhibition compared with those with ischemic MMD, but the latter group presented a worse working memory and poorer sustained attention. There were no significant differences in the DEX scores between the patients with MMD and healthy controls. The other findings were as follows: CBF was significantly positively correlated with the number correct on part B of the HSCT (r = 0.481, p = 0.01) and accuracy on the 0-back task of the N-back (r = 0.346, p = 0.031); MTT was significantly positively correlated with accuracy on the 2-back task of the N-back (r = 0.349, p = 0.034) and factor 5 of the DEX (r = 0.359, p = 0.032); and TTP was significantly positively correlated with the number correct on part B of the HSCT (r = 0.402, p = 0.034) and the 1-back reaction time of the N-back (r = 0.356, p = 0.026). CONCLUSIONS The patients with MMD exhibited impairments in semantic inhibition, executive processing, working memory, and sustained attention, but they were not aware of these deficits. Moreover, differences in dysexecutive function existed between the different subtypes of MMD. Hypoperfusion of the frontal lobe may be related to working memory and semantic inhibition impairments in patients with MMD.

Entities:  

Keywords:  CBF = cerebral blood flow; CBV = cerebral blood volume; CTP = CT perfusion; DEX = dysexecutive questionnaire; HSCT = Hayling Sentence Completion Test; ICA = internal carotid artery; MMD = moyamoya disease; MTT = mean transit time; ROI = region of interest; RT = reaction time; SART = Sustained Attention to Response Task; TIA = transient ischemic attack; TTP = time-to-peak; VF = verbal fluency; dysexecutive function; moyamoya disease; presentation; vascular disorders

Mesh:

Year:  2016        PMID: 26722860     DOI: 10.3171/2015.7.JNS142666

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  8 in total

1.  Evidence of dysexecutive syndrome in patients with acromegaly.

Authors:  Shaobo Shan; Lingling Fang; Jia Huang; Raymond C K Chan; Guijun Jia; Weiqing Wan
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

2.  Reorganization of the Brain Structural Covariance Network in Ischemic Moyamoya Disease Revealed by Graph Theoretical Analysis.

Authors:  Peijing Wang; Wenjie Li; Huan Zhu; Xingju Liu; Tao Yu; Dong Zhang; Yan Zhang
Journal:  Front Aging Neurosci       Date:  2022-06-02       Impact factor: 5.702

3.  Impairments in brain perfusion, executive control network, topological characteristics, and neurocognition in adult patients with asymptomatic Moyamoya disease.

Authors:  Shihao He; Ziqi Liu; Yanchang Wei; Ran Duan; Zongsheng Xu; Cai Zhang; Li Yuan; Tian Li; Ning Ma; Xin Lou; Xiaoyuan Liu; Rong Wang
Journal:  BMC Neurosci       Date:  2021-05-12       Impact factor: 3.288

4.  Mapping altered brain connectivity and its clinical associations in adult moyamoya disease: A resting-state functional MRI study.

Authors:  Ken Kazumata; Khin Khin Tha; Haruto Uchino; Masaki Ito; Naoki Nakayama; Takeo Abumiya
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

5.  Pediatric moyamoya disease presenting as attention deficit hyperactivity disorder: Time to pay attention.

Authors:  Suravi Patra; Ashis Patnaik
Journal:  Indian J Psychiatry       Date:  2019 Sep-Oct       Impact factor: 1.759

6.  Cognitive Performance Profile in Pediatric Moyamoya Disease Patients and Its Relationship With Regional Cerebral Blood Perfusion.

Authors:  Jiaxi Li; Xingju Liu; Dong Zhang; Yan Zhang; Rong Wang; Jing Yuan; Jizong Zhao
Journal:  Front Neurol       Date:  2019-12-12       Impact factor: 4.003

7.  Microstructural damage pattern of vascular cognitive impairment: a comparison between moyamoya disease and cerebrovascular atherosclerotic disease.

Authors:  Jia-Bin Su; Si-Da Xi; Shu-Yi Zhou; Xin Zhang; Shen-Hong Jiang; Bin Xu; Liang Chen; Yu Lei; Chao Gao; Yu-Xiang Gu
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135

8.  Different aspects of cognitive function in adult patients with moyamoya disease and its clinical subtypes.

Authors:  Zhiyong Shi; Yu-Jie Wen; Zheng Huang; Le-Bao Yu; Dong Zhang
Journal:  Stroke Vasc Neurol       Date:  2020-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.